Börsipäev 26. jaanuar
Kommentaari jätmiseks loo konto või logi sisse
-
Kahepäevane FOMC kohtumine päädis eile sõnumiga, et intressimäärad jäävad USAs madalaks (ehk kuni 1%) vähemalt 2014.a lõpuni, mis on kauem kui varasemalt pakutud 2013.a keskpaik ja ehk mõnevõrra üllatav arvestades viimase aja paranenud makrot. See ei ole aga FOMC liikmete üksmeelne otsus, sest 17st 6 arvasid, et intresse tuleks hakata tõstma juba sellel või järgmisel aastal. Ühtlasi seadis FED eesmärgiks saavutada pikaajalist 2%list inflatsiooni, mis on varasema vahemiku (1,75%-2%) ülemises ääres ning pressikonverentsil ei välistanud Bernanke ka aastase THI tõusmist mõnda aega üle 2%, et ergutada majandust ning võimaldada töötusemääral edasi langeda. USA selle aasta majandusprognoose tõmmati veidi allapoole, olles nüüd 2,2%-2,7% vs 2,5%-2,9% varem.
Kuigi ühest küljest viitab odava laenuraha pakkumise pikendamine ebastabiilsele ja kesisemale majanduslikule väljavaatele, siis lootus, et keskpank võiks ühel hetkel raha trükkima hakata, vedas USA turud ligi protsendisesse plussi ning toetab sentmenti ka täna Aasias ja Euroopas.
Tänase makro fookus langeb USA-le, kus kell 15.30 avalikustatakse detsembri kestvuskaupade tellimuste muutus, möödunud nädala esmaste töötuabiraha taotluste arv, kell 17.00 detsembri uute majade müük ja juhtivate indikaatorite indeks.
Oma majandustulemused raporteerivad enne turgu näiteks 3M, AT&T, Caterpillar, Colgate-Palmolive, Lockheed Martin, Nokia.
USA indeksite futuurid kauplevad hetkel kerges miinuses. -
Lisasime Balti Pro alla Balti ettevõtete kvartalitulemuste prognoosid. Lähemalt siit: https://fp.lhv.ee/pro/news/4580024
-
Caterpillari tugevad tulemused ning kõrgemad prognoosid lisavad kindlustunnet globaalsete majandusväljavaadete osas
Caterpillar prelim $2.32 vs $1.77 Capital IQ Consensus Estimate; revs $17.24 bln vs $16.02 bln Capital IQ Consensus Estimate
Caterpillar sees FY12 EPS of $9.25 vs $9.07 Capital IQ Consensus Estimate; raises revs to $68-72 bln from ~$64-70 vs $67.69 bln Capital IQ Consensus Estimate -
Portugali 10-aastase võlakirja tulusus on esmakordselt tõusnud üle 15% piiri. Hetke seisuga veidi langenud ja asub 14,87% juures.
-
Millal Portugal defaulti läheb? Isegi Kreekalt ei küsita nii palju.
-
winger
Millal Portugal defaulti läheb? Isegi Kreekalt ei küsita nii palju.
Kreekal 10-aastase tulusus 33,5%. -
Selge, mäletasin valesti.
Tulles Portugali juurde - Itaalia ägas juba >7% peal. Portugalil pole muid valikuid ja on rõõmsad 15% intressiga?
Ei jälgi sealset seisu või arenguid. -
Gapping up
In reaction to strong earnings/guidance: EGBN +27.1% (ticking higher), NFLX +19.3%, RJET +18.3%, (light volume), MLNX +14.4%, TER +6.8%, LSI +6.4%, URI +5.5%, JBLU +4.7%, TWC +4.4%, (light volume), NOK +3.2%, CAT +3.2%, UAL +2.8%, SYMC +1.1%, MMM +1.1%.
M&A news: MITI (halted) to be acquired by AMGN for $11 per share in cash, THOR +0.7% (Thoratec discloses IT received a proxy proposal from Oracle Partners; following discussions Oracle withdrew the Proposal).
Select financial related names showing strength: NBG +10.1%, IRE +7.7%, BCS +3.1%, ING +1.6%, BAC +1.2%, DB +1.1%, .
Metals/mining stocks trading higher: RIO +2.5%, AU +1.9%, MT +1.9%, BBL +1.2%, GFI +1.2%, BHP +0.8%, GDX +0.7%, GLD +0.2%, .
A few CAT peers are lifting premarket: TEX +2.7%, DE +2.6%, CMI +2.3%.
Other news: ROSG +9.1% (seeing continued strength), MDSO +6.4% (will replace RightNow Technologies (RNOW) in the S&P SmallCap 600 index ), RYAAY +5% (still checking), ELN +2.3% (ASCEND Study to Evaluate the Effectiveness of TYSABRI as a treatment for secondary-progressive multiple sclerosis).
Analyst comments: NVDA +1% (Nvidia upgraded to Positive from Neutral at Susquehanna), LIFE +0.8% (light volume, upgraded to Outperform from Market Perform at Leerink). -
winger, minuteada Portugal ei laena praegu vaid elatub abipakettidest. Hetkel on see intress neile samamoodi suht poogen nagu ka Kreekale. Itaalial pole aga abi kusagilt loota.
-
Gapping down
In reaction to disappointing earnings/guidance: LOGI -13.7%, CRR -13%, ETFC -10.1%, MWW -9.8%, CVD -9.7% (also authorizes $300 million stock buyback), SNDK -7.7%, UA -7.1%, MIPS -4.7%, VAR -4.3%, TZOO -3%, CY -2.3% (light volume), T -2.2%, LRCX -2.2%, CTXS -0.8%.
Other news: FTWR -44.4% (announces engagement of financial advisor & receipt of delisting notice), TSRX -7.8% (announced an offering for an undisclosed amount), GOF -4.2% (Guggenheim Strategic Opportunities Fund announces offering of 1.5 mln common shares), TS -2.3% (still checking).
Analyst comments: CHK -2.6% (downgraded to Underweight at JPMorgan), CLNE -2.4% (downgraded to Market Perform from Outperform at Raymond James), PGR -1% (ticking lower, downgraded to Sell from Neutral at Goldman), GD -0.6% (downgraded to Perform from Outperform at Oppenheimer). -
Continuing Claims rises to 3.554 mln from 3.466 mln
December Durable Orders ex-auto +2.1% vs +0.7% Briefing.com consensus; Prior revised to +0.5% from +0.3%
December Durable Orders +3% vs +2.0% Briefing.com consensus; prior revised to +4.3% from +3.7%
Initial Claims 377K vs 375K Briefing.com consensus; Prior revised to 356K from 352K -
Blame It on Bernanke
By James "Rev Shark" DePorre
Jan 26, 2012 | 8:56 AM
"The U.S. government has a technology, called a printing press (or today, its electronic equivalent), that allows it to produce as many U.S. dollars as it wishes at no cost." -- Federal Reserve Chairman Ben Bernanke in a speech to the National Economists Club, Nov. 21, 2002
The stock market loves a big supply of cheap money, and Big Bernank made it clear Wednesday that he is very open to this idea. The Federal Reserve made no promises but indicated in its policy statement that it would stay highly accommodative, and at the press conference Ben Bernanke seemed to have few concerns about another round of quantitative easing.
Even though the market was extended and struggling with a "sell-the-news" reaction to Apple's (AAPL) great earnings report, Dr. Bernanke's hints about endless cheap money ignited the buyers and sent them scurrying to snap up euros, precious metals, oils and commodities. Once again, the bears who keep looking for a reversal were caught trying to fight an extended market and ended up sending it even higher as they were squeezed.
The big issue now is whether this hint about quantitative easing is going to have legs to run on. It was just a hint, not a guarantee, and it carried conditions. There are very harsh critics of further quantitative easing, and there are political headwinds as well, so it is definitely not a done deal, especially if the economy doesn't falter.
We are back in a very familiar place, with a market technically extended on low volume, but buyers who have been anxious to jump in are not allowing even a minor pullback. The underlying strength since the first of the year has been extremely impressive with no pullback lasting longer than a few hours. There has been no sign of profit-taking; the dip buyers reflexively jump in on any pullback.
The economic data this morning are strong, which is driving the market. That is a bit inconsistent since the economic data is weak. That will push the Fed to offer the much desired quantitative easing.
The bulls have momentum, but we are in nosebleed territory and have a very narrow foundation of support. The key is to continue to hold the opening levels and not reverse intraday. It is tough to put new money to work, but it's even tougher to short this action.
At the time of publication, Rev Shark had no positions in the stocks mentioned. -
December New Home Sales 307K vs 321K Briefing.com consensus; prior revised to 314K from 315K
December Leading Indicators +0.4% vs +0.7% Briefing.com consensus -
GMCR on päevasiseselt nõrkust näitamas, kuna väidetavalt plaanib Wal-Mart (WMT) koostöös ESIO-ga tuua turule konkureeriva toote ehk oma "ühetassi" kohvimasina ja seda märksa madalama hinnaga.
GMCR kaupleb hetkel $ 48,90 juures, 4,1% miinuspoolel. -
EC's Junker saying that IMF is not pushing for the ECB to take Greek debt losses
-
Star Scientific announces Magistrate Judge appointed in Star Scientific patent infringement lawsuit against RJ Reynolds
-
K-V Pharmaceutical: Mark Kingdon discloses 7.05% stake in 13G filing
-
Täna öösel uuendatakse LHV Traderi versiooni.
Praegune versioon 911.3
Uus versioon 922
Uue versiooniga tulevad uued huvitavad võimalused, millest tooks esile järgmised:
Alusvara otsingu uuendused, kus on nüüd kasutatavad ka ISIN ja CUSIP.
FX paaride kiirsisestud:
Näiteks trükkides EUR.USD alusvara reale avaneb automaatselt noteeringute paneel.
Samuti on võimalik kontrollida võetava positsiooni tagatise nõudeid.
Ja kauplejatele suunatud nn. hõljuv noteeringute aken. Väike aken, kuhu saab enda jaoks olulisemad asjad sisestada ja mida saab enda käe järgi kuhgi vedada.
Edukat kauplemist! -
DeVry prelim $0.92 vs $1.00 Capital IQ Consensus Estimate; revs $524 mln vs $535.55 mln Capital IQ Consensus Estimate
-
Starbucks prelim $0.50 vs $0.48 Capital IQ Consensus Estimate; revs $3.44 bln vs $3.29 bln Capital IQ Consensus Estimate
-
Amgen prelim $1.21 vs $1.22 Capital IQ Consensus Estimate; revs $3.97 bln vs $3.92 bln Capital IQ Consensus Estimate
-
Juniper Networks prelim $0.28 vs $0.27 Capital IQ Consensus Estimate; revs $1.12 bln vs $1.12 bln Capital IQ Consensus Estimate
Riverbed Technology prelim $0.25 vs $0.24 Capital IQ Consensus Estimate; revs $203 mln vs $201.04 mln Capital IQ Consensus Estimate -
Starbucks sees FY12 $1.78-1.82 vs $1.84 Capital IQ Consensus Estimate; sees revs $12.87 bln vs $13.04 bln Capital IQ Consensus Estimate
